Try our Advanced Search for more refined results
Health
-
March 10, 2026
Sanofi Says Judge Botched Insulin Device Patent Listings
Sanofi-Aventis sparred with drug wholesalers over a Massachusetts federal magistrate judge's pronouncements that the parties should go to trial on claims the pharmaceutical giant used improper insulin device patent listings to anticompetitively protect the blockbuster Lantus insulin pen from competition.
-
March 10, 2026
Lab's Aetna Payment Suit Survives, But With Deep Cuts
A Connecticut federal judge ruled Aetna and its parent company, CVS Health Corp., must face a pared down lawsuit from a medical laboratory alleging it is owed $20.6 million in unpaid invoices.
-
March 10, 2026
FDA To Consider Coffee, 'Spice' E-Cig Flavors
The U.S. Food and Drug Administration on Monday indicated that it would be willing to consider e-cigarette flavors shown to be less attractive to youth, like coffee or spices, a move that's come under fire from public health advocates.
-
March 10, 2026
Wash. To Set Its Own Vaccine Schedule Under New State Law
Washington Gov. Bob Ferguson has signed legislation that requires health plans to cover vaccines and other preventive care recommended by the state rather than the federal government, joining a movement toward states setting their own recommendations.
-
March 10, 2026
4th Circ. Backs W.Va.'s Trans Care Coverage Exclusion
The Fourth Circuit said Tuesday that West Virginia's Medicaid coverage exclusion for gender-affirming care passes constitutional muster and does not discriminate based on sex, basing its conclusion on a U.S. Supreme Court ruling that upheld Tennessee's ban on gender-affirming care for minors.
-
March 10, 2026
CVS Can't 'Relitigate' Price-Gouging Class Cert.
A Rhode Island federal judge refused to narrow the certified classes of health plans alleging CVS schemed with pharmacy benefit managers to overcharge insured health plans for generic drugs, finding that PBM Express Scripts' refusal to produce its contracts changes nothing about how the classes will be assessed.
-
March 10, 2026
2nd Circ. Revives Geico's Suit Over Acupuncture Referrals
A lower court erred in granting summary judgment to Geico after the insurer sued over reimbursements to an acupuncturist involved in what Geico said was a kickback scheme, the Second Circuit ruled Tuesday, finding the district court misinterpreted a state law detailing requirements for referrals and no-fault payments.
-
March 10, 2026
Liberty Mutual Says Mich. Clinics Ran RICO Billing Scheme
Liberty Mutual has sued a group of Michigan medical providers, a physician and related businesses, claiming the collective ran a coordinated no-fault billing scheme that steered auto accident patients through affiliated providers to generate unnecessary medical bills.
-
March 10, 2026
Former Conn. Prosecutor Can Stay On Generic-Drug Case
Connecticut's former assistant attorney general can continue to represent insurers Humana and Molina Healthcare Inc. in multidistrict litigation over alleged price-fixing of generic drugs, after the Pennsylvania federal judge overseeing the case agreed Monday with a report that the attorney has no information that had not already been shared.
-
March 10, 2026
Medtronic Expands Vascular Device Line With $550M Deal
Medtronic said Tuesday it will acquire privately held Scientia Vascular for about $550 million, strengthening its portfolio of devices used to treat stroke and other neurovascular conditions.
-
March 10, 2026
AFSCME Sues Trump Admin Over $600M Health Funding Cuts
The American Federation of State, County and Municipal Employees is seeking to block a federal government directive to cancel more than $600 million in public health grants administered by the Centers for Disease Control and Prevention, alleging that the directive was issued to target Democratic-led states.
-
March 10, 2026
Judge Urges Resolution In NY Nursing Home Ch. 11
A New York bankruptcy court Tuesday pushed back the disclosure statement hearing in the Chapter 11 case of Long Island nursing home operator Cold Spring Acquisition, after the debtor said it is continuing to negotiate with its official committee of unsecured creditors over the administration of its liquidation plan.
-
March 09, 2026
Fla. Judge Finds Leapfrog's Hospital Ratings Deceptive, Unfair
A Florida federal judge ordered hospital ratings nonprofit Leapfrog to revoke poor safety grades it issued to five hospitals owned by Tenet Healthcare Corp., finding the group's approach to evaluating the hospitals and publicizing its findings was unfair and deceptive.
-
March 09, 2026
Texas AG Gets Temporary Ban On Chest Binder Sales
A Texas state judge has issued a temporary restraining order against a New York-based online retailer of undergarments and chest binders for young women and teens from selling its clothing in the Lone Star State.
-
March 09, 2026
Vehicle Manufacturer Strikes Deal In Tobacco Surcharge Suit
Commercial vehicle manufacturer International Motors LLC has agreed to end a proposed class action claiming it unlawfully charges employees who use tobacco products an additional $600 per year for health insurance without providing an alternative to the fee, according to a filing in Illinois federal court.
-
March 09, 2026
Abbott Formula Linked To 'Horrible' Gut Disease, Ill. Jury Told
Abbott Laboratories' preterm baby formula was a contributing factor that caused four premature infants born in Illinois to develop a "devastating and painful intestinal disease," and the company has failed to warn parents and physicians that the cow's milk-based formula is a risk factor for the condition, a Cook County jury heard Monday.
-
March 09, 2026
Abortion Rights Group, SD Agree to End Gas Station Ads Row
An abortion rights group can no longer post advertisements at gas stations in South Dakota that promote abortion care, the South Dakota attorney general's office announced on Monday, saying that the group and the state have reached an agreement in a pair of lawsuits over the advertising campaign.
-
March 09, 2026
Verano Receipts Out Medical Pot Users, Suit Claims
An Illinois man is suing cannabis giant Verano Holdings LLC in state court, alleging that it is in violation of state and federal privacy laws because it includes the buyer's name and date of birth on receipts for purchases at its dispensaries.
-
March 09, 2026
Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together
Novo Nordisk A/S will start selling its GLP-1 medications on Hims & Hers Health Inc.'s platform as part of a deal that resolves the pharmaceutical company's patent infringement lawsuit against the telehealth provider, the companies announced Monday.
-
March 09, 2026
Biopharma Brass Hid Drug Trial Risks, Derivative Suit Says
Brass of Ultragenyx Pharmaceutical Inc. are facing shareholder derivative claims they caused the company to overstate prospects for a drug to treat a bone disease, hurting investors and opening the company up to liability when its share prices fell following disappointing clinical trial news.
-
March 09, 2026
DC Circ. Skeptical That Review Of $100K H-1B Fee Is Foreclosed
Two members of a D.C. Circuit panel appeared uneasy Monday with the Trump administration's argument that the president's proclamation imposing a $100,000 payment for new H-1B petitions and accompanying agency actions implementing it are beyond judicial review.
-
March 09, 2026
McGuireWoods Beats Sun Pharma's DQ Bid In NJ Suit
A New Jersey federal court has denied Sun Pharmaceutical's bid to disqualify McGuireWoods LLP from representing pharmaceutical company Biofrontera in litigation over the alleged breach of a settlement agreement, ruling the firm's continued representation won't harm Sun Pharmaceutical and will avoid significant harm to Biofrontera.
-
March 09, 2026
3 Convicted Of Using Dental Practice To Defraud Medicare
A Pennsylvania jury on Monday convicted two of three brothers and an associate accused of using their dental practice to defraud Medicare by submitting bogus reimbursement claims, installing unapproved dental implants and doctoring visa paperwork to recruit workers from abroad.
-
March 09, 2026
3 Firms Advise On Talkspace's $835M Planned Sale To UHS
Universal Health Services has agreed to acquire virtual mental health company Talkspace at an enterprise value of about $835 million, the hospital operator said on Monday, as it looks to expand its outpatient and telehealth behavioral health services.
-
March 09, 2026
NC Providers Sue UnitedHealth Over 'Devastating' Cyberattack
UnitedHealth Group Inc. and several of its subsidiaries are facing a proposed class action in North Carolina state court over a 2024 data breach that took its claims processing platform offline and allegedly delayed billions of dollars in reimbursements to providers.
Expert Analysis
-
Series
Law School's Missed Lessons: What Cross-Selling Truly Takes
Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.
-
How State FCA Activity May Affect Civil Fraud Enforcement
A growing trend of state attorneys general enforcing their False Claims Act analogues independently of the U.S. Department of Justice carries potential repercussions for civil fraud enforcement and qui tam litigation considerations, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwen Stamper at Vogel Slade.
-
Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms
Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates awaiting bar admission should consider their options, as the work performed by such candidates may sit at the intersection of multiple occupational classifications with differing chances of success, says Jun Li at Reid & Wise.
-
Series
Judges On AI: Practical Use Cases In Chambers
U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.
-
Assessing Compliance Risks Around TrumpRx Participation
As there are novel compliance obligations and potential political opposition related to the new TrumpRx online drug platform, companies intending to participate on the site should consider the pressure points that are likely to draw enforcement scrutiny, say attorneys at Sheppard.
-
California's New Privacy Laws Demand Preparation From Cos.
An increase in breach disclosures is coinciding with California's most comprehensive privacy and artificial intelligence legislation taking effect, illustrating the range of vulnerabilities organizations in the state face and highlighting that the key to successfully managing these requirements is investing in capabilities before they became urgent, says Camilo Artiga-Purcell at Kiteworks.
-
Series
Trail Running Makes Me A Better Lawyer
Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.
-
Predicting Actual Impact From CDC's New Vaccine Guidance
Recent federal changes to the childhood immunization schedule, reducing the number of vaccine recommendations from 18 to 11, do not automatically create enforceable obligations for parents, schools or healthcare providers, but may spur litigation and other downstream effects on school policies and state guidelines, says Mehdi Sinaki at Michelman & Robinson.
-
AI Scientific Discovery Order Implications For Life Sciences
President Donald Trump's November executive order establishing a government effort to use artificial intelligence to accelerate scientific discovery has the potential to leverage significant federal resources and data to support research, drug and device approvals, and AI model training in the life sciences sector, say attorneys at Hogan Lovells.
-
What Rescheduling Means For Cannabis Labels, Marketing
The proposed reclassification of cannabis is expected to bring heightened scrutiny of labeling, advertising and marketing from the U.S. Food and Drug Administration and the Federal Trade Commission, but the brands that tighten evidence, standardize operations and professionalize marketing controls now will see fewer surprises and better outcomes, say attorneys at Wilson Elser.
-
What's At Stake In Possible Circuit Split On Medicaid Rule
A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.
-
Malpractice Claim Assignability Continues To Divide Courts
Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.
-
Courts' Rare Quash Of DOJ Subpoenas Has Lessons For Cos.
In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, demonstrating that courts will scrutinize purpose, cabin statutory authority and acknowledge the profound privacy burdens of overbroad government demands for sensitive records, say attorneys at ArentFox Schiff.
-
Unpacking Dormant Commerce Clause Cannabis Circuit Split
Federal courts have reached differing conclusions as to whether state-legal cannabis is subject to the dormant commerce clause, with four opinions across three circuit courts in the last year demonstrating the continued salience of the dormant commerce clause debate to the nation's cannabis industry, regulators and policymakers, say attorneys at Perkins Coie.
-
Remote Patient Monitoring Is At Regulatory Inflection Point
With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Department of Health and Human Services' Office of Inspector General examining Medicare billing for those services, it is clear that balancing innovation and risk will be a central challenge ahead for digital health stakeholders, say attorneys at Morgan Lewis.